Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: an in vivo microdialysis study - PubMed (original) (raw)
. 1996 Dec;354(6):785-90.
doi: 10.1007/BF00166906.
Affiliations
- PMID: 8971740
- DOI: 10.1007/BF00166906
Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: an in vivo microdialysis study
I Malagié et al. Naunyn Schmiedebergs Arch Pharmacol. 1996 Dec.
Abstract
We studied the changes in extracellular serotonin (5-HT) levels in the frontal cortex (FC) and ventral hippocampus (vHi) in conscious rats, induced by the combined administration of a highly selective 5-HT1A receptor antagonist, WAY 100635 (0.1 mg/kg, i.v.), and fluoxetine (1 mg/kg, i.p.), a selective 5-HT reuptake inhibitor (SSRI). In the two brain areas studied, no change in extracellular 5-HT concentrations was observed following fluoxetine administration over the 210 min post-injection period. However, in animals co-administered with [WAY 100635 + fluoxetine], the maximal increase in 5-HT levels in the FC was to 215% of the respective basal value (100%), while no significant change in 5-HT was observed in dialysates from the vHi. Furthermore, the [norfluoxetine]-to-[fluoxetine] ratio in the FC was significantly higher than in the hippocampus as measured in homogenates of animals treated with either fluoxetine alone or a prior administration of WAY 100635. Thus, WAY 100635 made the fluoxetine short-lasting effect apparent in the FC, but not by interfering with pharmacokinetic parameters of fluoxetine. Taken together, our data suggest the possibility, that either 5-HT1A autoreceptor sensitivity or uptake carrier density or higher [metabolite]-to-[parent drug] ratios in the FC than in the hippocampus may be involved in regional specific responses to SSRIs.
Similar articles
- Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
Invernizzi R, Bramante M, Samanin R. Invernizzi R, et al. Pharmacol Biochem Behav. 1996 May;54(1):143-7. doi: 10.1016/0091-3057(95)02159-0. Pharmacol Biochem Behav. 1996. PMID: 8728551 - Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors.
Hervás I, Artigas F. Hervás I, et al. Eur J Pharmacol. 1998 Sep 25;358(1):9-18. doi: 10.1016/s0014-2999(98)00579-2. Eur J Pharmacol. 1998. PMID: 9809863 - Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
Sharp T, Umbers V, Gartside SE. Sharp T, et al. Br J Pharmacol. 1997 Jul;121(5):941-6. doi: 10.1038/sj.bjp.0701235. Br J Pharmacol. 1997. PMID: 9222551 Free PMC article.
Cited by
- Pharmacokinetic and metabolism studies using microdialysis sampling.
Hansen DK, Davies MI, Lunte SM, Lunte CE. Hansen DK, et al. J Pharm Sci. 1999 Jan;88(1):14-27. doi: 10.1021/js9801485. J Pharm Sci. 1999. PMID: 9874697 Free PMC article. Review. No abstract available. - Computational Analysis of Therapeutic Neuroadaptation to Chronic Antidepressant in a Model of the Monoaminergic Neurotransmitter and Stress Hormone Systems.
Camacho MB, Vijitbenjaronk WD, Anastasio TJ. Camacho MB, et al. Front Pharmacol. 2019 Oct 25;10:1215. doi: 10.3389/fphar.2019.01215. eCollection 2019. Front Pharmacol. 2019. PMID: 31708770 Free PMC article. - Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat.
Hervás I, Queiroz CM, Adell A, Artigas F. Hervás I, et al. Br J Pharmacol. 2000 May;130(1):160-6. doi: 10.1038/sj.bjp.0703297. Br J Pharmacol. 2000. PMID: 10781012 Free PMC article. - Antidepressant activity: contribution of brain microdialysis in knock-out mice to the understanding of BDNF/5-HT transporter/5-HT autoreceptor interactions.
Gardier AM. Gardier AM. Front Pharmacol. 2013 Aug 8;4:98. doi: 10.3389/fphar.2013.00098. eCollection 2013. Front Pharmacol. 2013. PMID: 23964240 Free PMC article.
References
- Eur J Pharmacol. 1995 Nov 14;286(2):213-7 - PubMed
- Brain Res. 1992 Jul 3;584(1-2):322-4 - PubMed
- Synapse. 1987;1(1):3-9 - PubMed
- J Pharmacol Exp Ther. 1993 Jun;265(3):1319-24 - PubMed
- J Neurochem. 1993 Feb;60(2):776-9 - PubMed